Skip to main content
. 2024 Oct 30;31(5):766–773. doi: 10.5603/cj.102195

Figure 1.

Figure 1

Study design of the TELE-SPACER trial and registry, MACE — major adverse cardiac events; QOL — quality of life; VAS — visual analog scale